Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 36.02%21.68M | -12.21%32.94M | -17.23%15.94M | 3,134.40%37.52M | 4,547.58%19.26M | 139.11%1.16M | -949.02%-433K | -185.38%-2.97M | -98.34%51K | -75.93%3.47M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 27.83%-643K | -60.54%-1.49M | -92.03%-891K | -46.46%-930K | -215.65%-464K | -522.55%-635K | -90.91%-147K | 90.63%-102K | 88.97%-77K | 17.14%-1.09M |
| Impairment and provisions: | -165.15%-200K | 1,405.43%1.2M | 690.38%307K | 92.54%-92K | 92.35%-52K | -722.00%-1.23M | -75.26%-680K | -104.44%-150K | -140.46%-388K | 468.52%3.38M |
| -Impairmen of inventory (reversal) | -165.15%-200K | 1,405.43%1.2M | 690.38%307K | 92.54%-92K | 92.35%-52K | -722.00%-1.23M | -75.26%-680K | -112.12%-150K | -140.46%-388K | 108.42%1.24M |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.14M |
| Revaluation surplus: | 151.20%525K | -32.50%349K | -54.57%209K | 920.63%517K | --460K | ---63K | ---- | ---- | ---- | ---- |
| -Fair value of investment properties (increase) | 151.20%525K | -32.50%349K | -54.57%209K | 920.63%517K | --460K | ---63K | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | --6K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | --6K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | 13.92%8.64M | 6.16%16.18M | -0.99%7.58M | 3.42%15.24M | 4.67%7.66M | 0.44%14.73M | -1.64%7.32M | -10.51%14.67M | -9.38%7.44M | 0.07%16.39M |
| Financial expense | -12.10%494K | 5.25%1.18M | 11.73%562K | 97.89%1.12M | 147.78%503K | 74.23%568K | 14.69%203K | -40.07%326K | -43.63%177K | -30.88%544K |
| Special items | ---- | ---- | 100.00%98K | 410.53%59K | --49K | -733.33%-19K | ---- | -70.00%3K | --3K | -81.13%10K |
| Operating profit before the change of operating capital | 28.10%30.5M | -5.78%50.35M | -13.15%23.81M | 268.25%53.44M | 337.85%27.41M | 23.18%14.51M | -13.11%6.26M | -48.12%11.78M | -39.22%7.21M | -26.59%22.71M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 54.91%-1.66M | 139.33%1.53M | 2.55%-3.67M | -163.41%-3.89M | 14.71%-3.77M | -193.44%-1.48M | -287.97%-4.42M | -138.19%-503K | 27.03%-1.14M | -41.23%1.32M |
| Accounts receivable (increase)decrease | -105.63%-7.59M | 71.67%-609K | 44.00%-3.69M | 80.64%-2.15M | -2,992.54%-6.6M | -334.06%-11.11M | -89.06%228K | 292.42%4.75M | -4.27%2.09M | -115.03%-2.47M |
| Accounts payable increase (decrease) | -60.27%642K | -76.85%344K | -50.40%1.62M | 210.73%1.49M | 200.46%3.26M | -151.91%-1.34M | -252.04%-3.24M | 133.94%2.59M | -46.55%2.13M | 116.36%1.11M |
| Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | ---91K | ---- | ---- | ---- | ---- |
| Cash from business operations | 21.21%21.89M | 5.58%51.62M | -11.08%18.06M | 9,736.82%48.89M | 1,831.29%20.31M | -97.33%497K | -111.40%-1.17M | -17.90%18.61M | -37.53%10.29M | -47.02%22.67M |
| Other taxs | -14.39%-1.64M | -2,119.05%-8.85M | -608.91%-1.43M | -131.22%-399K | 56.75%-202K | 337.99%1.28M | 11.39%-467K | -119.90%-537K | 27.81%-527K | --2.7M |
| Net cash from operations | 21.80%20.25M | -11.81%42.76M | -17.31%16.63M | 2,631.83%48.49M | 1,325.98%20.11M | -90.18%1.78M | -116.81%-1.64M | -28.75%18.07M | -37.98%9.76M | -23.36%25.36M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -27.83%643K | 60.54%1.49M | 92.03%891K | 46.46%930K | 215.65%464K | 522.55%635K | 90.91%147K | -90.63%102K | -88.97%77K | -17.14%1.09M |
| Decrease in deposits (increase) | -6,350.72%-8.63M | -350.03%-4.48M | 102.52%138K | -94.37%1.79M | 32.79%-5.47M | 2,256.40%31.84M | -135.99%-8.15M | -92.76%1.35M | 3,452.59%22.63M | 131.55%18.67M |
| Sale of fixed assets | ---- | ---- | ---- | --6K | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | 36.96%-435K | -17.11%-1.05M | -16.55%-690K | -3.71%-894K | -1,215.56%-592K | 36.20%-862K | -136.84%-45K | 92.53%-1.35M | 56.82%-19K | -3,627.22%-18.08M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---26.54M | ---- | ---- | ---- | ---- |
| Net cash from investment operations | -2,583.19%-8.42M | -319.97%-4.03M | 106.05%339K | -63.86%1.83M | 30.35%-5.6M | 4,872.55%5.07M | -135.45%-8.04M | -93.92%102K | 108,138.10%22.69M | 102.56%1.68M |
| Net cash before financing | -30.25%11.83M | -23.03%38.73M | 16.97%16.97M | 634.96%50.32M | 249.79%14.5M | -62.32%6.85M | -129.84%-9.68M | -32.79%18.17M | 106.49%32.45M | 183.37%27.04M |
| Cash flow from financing activities | ||||||||||
| Refund | 2.76%-247K | 0.20%-500K | -1.60%-254K | -317.50%-501K | ---250K | ---120K | ---- | ---- | ---- | ---- |
| Dividends paid - financing | ---- | -99.99%-15.24M | ---- | 0.01%-7.62M | ---- | 0.64%-7.62M | ---- | -1.31%-7.67M | ---50K | 66.35%-7.57M |
| Net cash from financing operations | -17.09%-7.98M | -40.77%-29.93M | -0.96%-6.81M | 1.92%-21.26M | 7.64%-6.75M | 1.63%-21.68M | -2.08%-7.31M | -0.12%-22.04M | -0.75%-7.16M | 31.99%-22.01M |
| Effect of rate | 18.18%39K | 129.89%78K | 112.99%33K | 6.79%-261K | 32.09%-254K | -923.53%-280K | -884.21%-374K | 47.83%34K | -337.50%-38K | 156.10%23K |
| Net Cash | -62.01%3.86M | -69.72%8.8M | 30.89%10.15M | 295.93%29.06M | 145.66%7.76M | -283.75%-14.83M | -167.17%-16.99M | -176.85%-3.87M | 193.73%25.29M | 107.76%5.03M |
| Begining period cash | 12.71%78.72M | 70.17%69.84M | 70.17%69.84M | -26.91%41.04M | -26.91%41.04M | -6.39%56.16M | -6.39%56.16M | 9.20%59.99M | 9.20%59.99M | -54.13%54.94M |
| Cash at the end | 3.24%82.62M | 12.71%78.72M | 64.85%80.03M | 70.17%69.84M | 25.14%48.55M | -26.91%41.04M | -54.49%38.79M | -6.39%56.16M | 34.11%85.24M | 9.20%59.99M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --85.24M | --59.99M |
| Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --85.24M | --59.99M |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Jiu'an (Hong Kong) Certified Public Accountants Limited | -- | Huarong (Hong Kong) Certified Public Accountants Limited | -- | Huarong (Hong Kong) Certified Public Accountants Limited | -- | Huarong (Hong Kong) Certified Public Accountants Limited | -- | Huilian Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.